An expanded concept of "insurance" supplementation--broad-spectrum protection from cardiovascular disease.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Medical Hypotheses

• Publication date

  1981-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0306-9877(81)90135-3PMID 6169979
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects and metabolism of glucose tolerance factor.

  2009cited by this paper
• Orthomolecular aids for dieting.

  1982cited by this paper
• Toward a "bio-energy supplement" -- a prototype for functional orthomolecular supplementation.

  1981cited by this paper
• Maturity-onset diabetes mellitus--toward a physiological appropriate management.

  1981cited by this paper
• Prospects for nutritional control of hypertension.

  1981cited by this paper
• Point of view--a role for "nutritional insurance" supplementation in preventive medicine.

  1981cited by this paper
• A new concept of lifestyle-related cardiovascular disease: the importance of interactions between cholesterol, essential fatty acids, prostaglandin E1 and thromboxane A2.

  1980cited by this paper
• Carnitine improves lipid anomalies in haemodialysis patients.

  1980cited by this paper
• Beneficial Effect of Chromium-rich Yeast on Glucose Tolerance and Blood Lipids in Elderly Subjects

  1980cited by this paper
• Effect of L-carnitine on lipid pattern in haemodialysis.

  1980cited by this paper
• The effect of chromium on established atherosclerotic plaques in rabbits.

  1980cited by this paper
• The therapeutic potential of glucose tolerance factor.

  1980cited by this paper
• Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.

  1979cited by this paper
• Sudden-death ischemic heart disease and dietary magnesium intake: is the target site coronary vascular smooth muscle?

  1979cited by this paper
• Vascular prostacyclin may be reduced in diabetes in man.

  1979cited by this paper
• Lipid metabolism in diabetes mellitus.

  1979cited by this paper
• Ischaemic heart disease-an hypothesis to integrate the role of insulin, fibre and sucrose.

  1979cited by this paper
• Insulin-independent diabetes: A defect in the activity of lipoprotein lipase in adipose tissue

  1979cited by this paper
• Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes

  1979cited by this paper
• Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension.

  1978cited by this paper
• Protection of the ischemic dog myocardium with carnitine.

  1978cited by this paper
• Metabolic regulation of plasma high density Iipoprotein concentrations

  1978cited by this paper
• Serum pyridoxal concentrations in patients with diabetic neuropathy.

  1978cited by this paper
• Preferential utilization of free cholesterol from high-density lipoproteins for biliary cholesterol secretion in man.

  1978cited by this paper
• LIPID-LOWERING EFFECT OF CARNITINE IN PATIENTS WITH TYPE-IV HYPERLIPOPROTEINÆMIA

  1978cited by this paper
• Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro.

  1978cited by this paper
• The action of prostaglandin E2 and F1alpha on myocardial ischaemia-infarction arrhythmias in the dog.

  1978cited by this paper
• Metabolic regulation of plasma high density lipoprotein concentrations.

  1978cited by this paper
• Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man.

  1978cited by this paper
• Nicotinic acid and inhibition of fat mobilizing lipolysis. Present status of effects on lipid metabolism.

  1978cited by this paper
• High high-density-lipoprotein cholesterol in African children and adults in a population free of coronary heart diseae.

  1978cited by this paper
• Lipid-lowering effect of carnitine in patients with type-IV hyperlipoproteinaemia.

  1978cited by this paper
• The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal

  1978cited by this paper
• Regulatory role of insulin in the degradation of low density lipoprotein by cultured human skin fibroblasts.

  1978cited by this paper
• High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

  1977cited by this paper
• The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

  1977cited by this paper
• Atherosclerosis: the low-density lipoprotein receptor hypothesis.

  1977cited by this paper
• On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.

  1977cited by this paper
• Antithrombotic potential of dihomo-gamma-linolenic acid in man.

  1977cited by this paper
• Effect of a diet of polyunsaturated fats on some platelet-function tests.

  1976cited by this paper
• Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.

  1976cited by this paper
• A clinical study of the effect of coenzyme Q on congestive heart failure.

  1976cited by this paper
• Influence of oral contraceptives, pyridoxine (vitamin B6), and tryptophan on carbohydrate metabolism.

  1976cited by this paper
• Atherosclerosis: the role of endothelial injury, smooth muscle proliferation and platelet factors.

  1976cited by this paper
• Potassium, Glucose and Insulin Administration in Acute Myocardial Infarction: A Five‐Year Study

  1976cited by this paper
• Bioenergetics in clinical medicine. VIII. Adminstration of coenzyme Q10 to patients with essential hypertension.

  1976cited by this paper
• Serum-high-density-lipoprotein in diabetic patients.

  1976cited by this paper
• The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes

  1976cited by this paper
• Prostaglandins and prostaglandin precursors as endogenous antiarrhythmic principles of the heart.

  1976cited by this paper
• Selenium in biology.

  1975cited by this paper
• Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.

  1975cited by this paper
• Studies on Magnesium's Mechanism of Action in Digitalis‐induced Arrhythmias

  1975cited by this paper
• Indomethacin and the role of prostaglandins in adipose tissue.

  1975cited by this paper
• Bioenergetics in clinical medicine. Studies on coenzyme Q10 and essential hypertension.

  1975cited by this paper
• Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

  1975cited by this paper
• Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

  1975cited by this paper
• The effectiveness of magnesium chloride in the treatment of ventricular tachyarrhythmias due to digitalis intoxication.

  1974cited by this paper
• Magnesium interrelationships in ischemic heart disease: a review.

  1974cited by this paper
• Insulin, andeyl cyclate, ions, and the heart.

  1974cited by this paper
• Thyroid thermogenesis.

  1974cited by this paper
• Influence of dietary fat on platelet function in men.

  1973cited by this paper
• Heart-muscle magnesium, potassium, and zinc concentrations after sudden death from heart-disease.

  1973cited by this paper
• Effect of treatment with nicotinic acid for one month on serum lipids in patients with different types of hyperlipidemia.

  1973cited by this paper
• Indomethacin, lipolysis, and cyclic AMP accumulation in white fat cells.

  1973cited by this paper
• Inhibition of functional vasodilatation and prostaglandin formation in rabbit adipose tissue by indomethacin and aspirin

  1973cited by this paper
• On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein.

  1973cited by this paper
• Precursors of plasma triglyceride fatty acid in humans. Effects of glucose consumption, clofibrate administration, and alcoholic fatty liver.

  1972cited by this paper
• Increased platelet aggregation in diabetes mellitus.

  1972cited by this paper
• The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.

  1972cited by this paper
• Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos.

  1971cited by this paper
• Comparison of the effects of prostaglandins E 1, E 2 and F 2 alpha on the sympathetically stimulated rabbit heart.

  1971cited by this paper
• Comparison of the Effects of Prostaglandins E1, E2 and F2α on the Sympathetically Stimulated Rabbit Heart

  1971cited by this paper
• Endogenous prostaglandins modulate lipolytic processes in adipose tissue.

  1971cited by this paper
• Effects of orotic acid on purine and lipoprotein metabolism in man.

  1970cited by this paper
• Insulin secretion in normal and diabetic individuals.

  1970cited by this paper
• Insulin secretion in normal and diabetic individuals.

  1970cited by this paper
• Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans.

  1970cited by this paper
• The effects of glucagon, dibutyryl cyclic adenosine 3',5'-monophosphate, and concentration of free fatty acid on hepatic lipid metabolism.

  1969cited by this paper
• Regulation of adipose tissue lipoprotein lipase synthesis by intracellular free fatty acid.

  1968cited by this paper
• Clinical Use of Coenzyme-Q for Treatment of Cardiovascular Diseases

  1967cited by this paper
• Prevalence and pathological changes of ischaemic heart-disease in a hard-water and in a soft-water area.

  1967cited by this paper
• The Role of Magnesium in Blood Coagulation

  1967cited by this paper
• Hypersensitivity olipid mobilizing agents in essential fatty acid (EFA) deficient rats.

  1967cited by this paper
• Depression of Plasma FFA Levels in Unanesthetized Dogs by Single Intravenous Doses of Prostaglandin E1

  1966cited by this paper
• EFFECT OF COENZYME Q7 TREATMENT ON BLOOD SUGAR AND KETONE BODIES OF DIABETICS

  1966cited by this paper
• Magnesium, Adenosine Diphosphate and Blood Platelets

  1966cited by this paper
• Taurine as a Regulator of Cell Potassium in the Heart

  1965cited by this paper
• PARENTERAL MAGNESIUM SULPHATE IN ARTERIAL DISEASE.

  1964cited by this paper
• PARENTERAL MAGNESIUM SULPHATE IN ARTERIAL DISEASE.

  1964cited by this paper
• Effect of Different Dietary Fats on Blood Coagulation, Platelet Economy, and Blood Lipids*

  1962cited by this paper
• [Effect of carnitine on diabetic hyperlipemia].

  1960cited by this paper
• Effet de la carnitine sur l'hyperlipidémie diabétique

  1960cited by this paper
• Anticholesterol Activity of α-Lipoic Acid

  1958cited by this paper
• Effect of lipotropic factors upon serum lipids and vascular disease in man.

  1958cited by this paper
• Anticholesterol activity of alpha-lipoic acid.

  1958cited by this paper
• [Not Available].

  1957cited by this paper
• Effect of Choline as a Lipotropic Agent in the Treatment of Human Coronary Atherosclerosis.∗ †

  1950cited by this paper
• Depressing Effect of Inositol on Serum Cholesterol and Lipid Phosphorus in Diabetics.∗

  1949cited by this paper
• Some experimental studies in hypercholesterolemic states.

  1947cited by this paper
• The action of choline on the blood lipid fractions in cirrhosis of the liver, diabetes mellitus and related conditions of disturbed fat metabolism.

  1947cited by this paper

• Is lipid profile in women with polycystic ovary syndrome related to calcium or magnesium in serum

  2009cites this paper
• Beneficial effect of dl-α-lipoic acid on cyclosporine A induced hyperlipidemic nephropathy in rats

  2007cites this paper
• Extracellular Matrix-Mediated Control of Aortic Smooth Muscle Cell Growth and Migration by a Combination of Ascorbic Acid, Lysine, Proline, and Catechins

  2007cites this paper
• Taurine analogues; a new class of therapeutics: retrospect and prospects.

  2005cites this paper
• Lipoic acid as a rescue agent for adriamycin-induced hyperlipidemic nephropathy in rats

  2003influential citation
• Effect of DL-alpha-lipoic acid on the status of lipid peroxidation and lipids in aged rats.

  2003cites this paper
• Effect of DL α-lipoic acid on tissue redox state in acute cadmium-challenged tissues

  1996cites this paper
• Impaired lipid metabolism in calcium oxalate stone forming rats and DL α - lipoic acid supplementation

  1995cites this paper
• Tissue lipids in experimental calcium oxalate lithiasis and the effect of DL alpha-lipoic acid.

  1992cites this paper
• Rationales for micronutrient supplementation in diabetes.

  1984cites this paper
• Chromium deficiency and cardiovascular risk.

  1984cites this paper
• Chromium and insulin.

  1982cites this paper
• Nutritional support of central catecholaminergic tone may aid smoking withdrawal.

  1982cites this paper